FDA NDC Directory · JSON-LD · Markdown

Fabrazyme

NDC 58468-0040 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameAGALSIDASE BETA
Labeler / ManufacturerGenzyme Corporation
Marketing categoryBiologic License Application · App BLA103979
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsAGALSIDASE BETA (5 mg/mL)
Marketing started20081217
Package count1

External sources

Source: openFDA. Public-domain (CC0).